Jin-Xiong She, founder of Jinfiniti Precision Medicine, explains: Most people assume their NAD+ is fine until they test it
General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Other Treatments Peptide therapy is a relatively new and promising treatment compared to more traditional weight loss or muscle-building methods
Many people are surprised to learn that vitamin B12 deficiency is a recognised contributor to nerve damage
B12 levels often peak within hours to days after supplementation and can remain elevated for several weeks, depending on the dose and individual metabolism
We do not provide guarantees that a shipment will successfully pass customs in your country
